Pharmaceutical

Image

Global Athlete′s Foot Drugs Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Athlete′s Foot Drugs Market, By Type (Interdigital, Mocassin, Vesicular), Treatment (Topical, Oral Antifungal Medication, Topical Oral Steroid, Oral Antibiotics), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2030.

Athlete′s foot Drugs Market

Athlete′s foot Drugs Market Analysis and Size

The global athlete′s foot drugs market is expected to witness significant growth during the forecast period. According to National Center for Biotechnology Information (NCBI) records, an athlete's foot is very common with an occurence rate of an estimated 3 to 15% of the population. Oral segment witnessed to have a huge growth and is readjusted to a revised 2.9% CAGR for the next 7-year period. The athlete's foot drug is used to treat fungal infection of the feet, which causes the scaling and blistering of the soles, fissures at toes, and painful and burning sensations along itching rashes.

Data Bridge Market Research analyses a growth rate in the global athlete′s foot drugs market in the forecast period 2023-2030. The expected CAGR of global athlete′s foot drugs market is tend to be around 6% in the mentioned forecast period. The market was valued at USD 0.94 billion in 2022, and it would grow upto USD 1.5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Athlete′s foot Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Interdigital, Mocassin, Vesicular), Treatment (Topical, Oral Antifungal Medication, Topical Oral Steroid, Oral Antibiotics), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Bausch Health Companies Inc. (Canada), DermBiont, Inc (U.S.), Blueberry Therapeutics Ltd (U.K.), Novan, Inc. (U.S.), Janssen Global Services, LLC (U.S.), Bayer AG (Germany), GSK plc (U.K.), Walgreen Co (U.S.), Qilu Pharmaceutical Co., Ltd. (China), Taisho Pharmaceutical Holdings Co., Ltd. (Japan), Taro Pharmaceutical Industries Ltd (U.S.)

Market Opportunities

  • Increasing Demand for Retail Pharmacies
  • Growing Strategic Acquisitions

Market Definition

Athlete's foot, also known as tinea pedis, is a type of viral infection of the fungus which affects the feet. This can spread to the toe nails and hands. It is more commonly seen in athletes, hence the name. The infection can cause scaling, itching, and blisters on the soles and sides of the feet. Athlete's foot drugs involves medications which are used to treat this condition. It includes antifungal medications such as terbinafine (Lamisil) and itraconazole (Sporanox), as well as topical corticosteroids such as betamethasone (Dermovate). These drugs help to clear up the infection and relieve symptoms.

Global Athlete′s foot Drugs Market Dynamics

Drivers

  • Increasing Cases of Sports Injuries

The increasing occurrence and incidence of several sports injuries boost the growth of the market. According to the British Journal of Sports Medicine, about 1 million people are treated for sports-related injuries every year in the U.K. and this number is projected to increase by 50% over the next few years. Thus, it acts as a major driver in the market growth.

  • Increase in the number of research and development activities       

The market's growth is fuelled by the rise in the number of R&D activities. This will provide beneficial opportunities for the global athlete′s foot drugs market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding research and development (R&D) initiatives.

Opportunities

  • Growing Strategic Acquisitions

The key market players are contributing majorly to the growth of the market by the adoption of numerous strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to involve in the competition in the market. For instance, in April 2021, Pfizer Inc. acquired Amplyx Pharmaceuticals. The aim is to develop a new treatment for drug-resistant "superbug" for antifungal treatment. Thus, all of these factors are projected to contribute to partial growth in the forecast period.  

  • Increasing Demand for Retail Pharmacies

The rise in the number of drugs used for global athlete′s foot drugs market delivered through retail pharmacies and the establishment in the number of retail pharmacies in developed countries create opportunities for the market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily available.

Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified healthcare professionals who are unable to perform these treatments could decrease the growth of the global athlete′s foot drugs market during a forecast period.

  • Unavailability of Appropriate Treatments

To treat conditions which are rare, sometimes all treatments are not available, particularly in the under-developed countries. The severe patients needs to be treated with the advanced techniques but at times, these are not available in the hospitals and clinics. Thus, it hampers the market growth.

This global athlete′s foot drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global athlete′s foot drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Athlete′s Foot Drugs Market Scope

The global athlete′s foot drugs market is segmented on the basis of type, treatment, route of administration, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Interdigital
  • Mocassin
  • Vesicular 

Treatment

  • Topical
  • Oral Antifungal Medication
  • Topical Oral Steroid
  • Oral Antibiotics

Route of Administration

  • Oral
  • Topical
  • Others

End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

Athlete′s Foot Drugs Market Regional Analysis/Insights

The global athlete′s foot drugs market is analysed and market size insights and trends are provided by type, treatment, route of administation, end-user, distribution channel as referenced above.

The major countries covered in the global athlete′s foot drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market due to easy access to healthcare facilities and increased investments in healthcare by leading market players.  

Asia-Pacific is considered to have the most lucrative period due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Athlete′s Foot Drugs Market Share Analysis

The global athlete′s foot drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global athlete′s foot drugs market.

Key players operating in the global athlete′s foot drugs market include:

  • Bausch Health Companies Inc. (Canada)
  • DermBiont, Inc (U.S.)
  • Blueberry Therapeutics Ltd (U.K.)
  • Novan, Inc. (U.S.)
  • Janssen Global Services, LLC (U.S.)
  • Bayer AG (Germany)
  • GSK plc (U.K.)
  • Walgreen Co (U.S.)
  • Qilu Pharmaceutical Co., Ltd. (China)
  • Taisho Pharmaceutical Holdings Co., Ltd. (Japan)
  • Taro Pharmaceutical Industries Ltd (U.S.)

Research Methodology: Global Athlete′s Foot Drugs Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Athlete′s Foot Drugs Market is projected to grow at a CAGR of 6.0% during the forecast period by 2030.
The future market value of the Athlete′s Foot Drugs Market is expected to reach USD 1.5 billion by 2030.
The major players in the Athlete′s Foot Drugs Market are Bausch Health Companies Inc. (Canada), DermBiont, Inc (U.S.), Blueberry Therapeutics Ltd (U.K.), Novan, Inc. (U.S.), Janssen Global Services, LLC (U.S.), Bayer AG (Germany), GSK plc (U.K.), etc.
The countries covered in the Athlete′s Foot Drugs Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials